Abstract
The Mouse Defense Test Battery (MDTB) has been designed to assess defensive reactions in Swiss-Webster mice to situations associated with a natural predator, the rat. Primary measures taken before, during and after predator confrontation comprise escape attempts, predator assessment, defensive attack and flight. Previous reports from this laboratory have shown that the panic-promoting drug yohimbine potentiated flight behavior, while long-term treatment with the panicolytic agent alprazolam reduced this response. In order to evaluate further the possibility that the MDTB may represent an effective animal model of panic attacks, the present study investigated the behavioral effect of imipramine and fluoxetine, two serotonin reuptake inhibitors (SRIs) known to alleviate panic symptoms when given on a repeated basis. Both drugs were administered acutely and chronically (one daily IP injection for 21 days) at 5, 10 and 15 mg/kg. Our results showed that a single dose of imipramine or fluoxetine strongly potentiated flight reactions in response to an approaching predator and increased defensive attack toward the rat. This was in contrast to chronic treatment with each drug which dramatically decreased flight responses and defensive attack behaviors. In addition, long-term administration with both SRIs produced a reliable attenuation of predator assessment activities. Taken together, these findings suggest an acute anxiogenic-like effect of imipramine and fluoxetine followed by a fear/anxiety reducing effect after repeated administrations. These results support clinical observations revealing an acute anxiogenic effect of SRIs followed by an anxiolytic and/or panicolytic effect after chronic use, and support previous results suggesting that the MDTB may be useful for the investigation of panic-modulating agents.
Similar content being viewed by others
References
Audi EA, de Aguiar JC, Graeff FG (1988) Mediation by serotonin of the antiaversive effect of zimelidine and propranolol injected into the dorsal midbrain central grey. J Psychopharmacol 2:26–32
Blanchard DC, Rodgers RJ, Hendrie CA, Hori K (1988) “Taming” of wild rats (Rattus rattus) by 5-HT1A agonists buspirone and gepirone. Pharmacol Biochem Behav 31:269–278
Blanchard DC, Hori K, Rodgers RJ, Hendrie CA, Blanchard RJ (1989) Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines. Psychopharmacology 97:392–401
Blanchard RJ, Blanchard DC, Weiss SM (1990) Ethanol effects in an anxiety/defense test battery. Alcohol 7:375–381
Blanchard RJ, Shepherd JK, Rodgers RJ, Magee L, Blanchard DC (1993a) Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology 110:245–253
Blanchard RJ, Taukulis HK, Rodgers RJ, Magee LK, Blanchard DC (1993b) Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice. Pharmacol Biochem Behav 44:673–681
Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95:298–302
Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ (1989) A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 97:277–279
Burnet PWJ, Michelson D, Smith MA, Gold PW, Sternberg EM (1994) The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hip-pocampus and dorsal raphe of three strains of rat. Brain Res 638:311–324
Cassella JV, Davis M (1985) Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 87:278–282
Craft RM, Howard JL, Pollard GT (1988) Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol Biochem Behav 30:775–780
Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defense. J Psychopharmacol 5:305–315
Deakin JFW, Guimaraes FS, Wang F, Hellewell J, Hensman R (1991) 5-HT receptor mechanisms in human anxiety. In: Briley M, File SE (eds) New concepts in anxiety. CRC Press, New York, pp 74–93
Den Boer JA, Westenberg HGM (1990) Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102:85–94
Dwyer KD, Roy EJ (1993) Juvenile desipramine reduces adult sensitivity to imipramine in two behavioral test. Pharmacol Biochem Behav 45:201–207
Fontana DJ, Commissaris RL (1988) Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential “animal model” for study of panic disorder? Psychopharmacology 95:147–150
Fuller RW (1993) Microdialysis studies with 5-HT reuptake inhibitors. Trends Pharmacol Sci 14:397
Fuller RW (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55:163–167
Garakani H, Zitrin CM, Klein DF (1984) Treatment of panic disorder with imipramine alone. Am J Psychiatry 141:446–448
Giesecke ME (1990) Overcoming hypersensitivity of fluoxetine in a patient with panic disorder. Am J Psychiatry 147:532–533
Gorman JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas RB, Fyer MR, Davies SO, Klein DF (1987 An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 7:329–332
Graeff FG (1990) Brain defense system and anxiety. In: Burrows GD, Roth M, Noyes R Jr (eds) Handbook of anxiety, vol. 3. The neurobiology of anxiety. Elsevier, Amsterdam, pp 307–343
Graeff FG (1991) Neurotransmitters in the dorsal periqueductual grey and animal models of panic anxiety. In: Briley M, File SE (eds) New concepts in anxiety CRC Press, New York, pp 288–307
Graeff FG, Brandão ML, Audi EA, Schütz MTB (1986) Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. Behav Brain Res 21:65–72
Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther:319–395
Griebel G, Blanchard RJ, Lee JC, Rodgers RJ, Blanchard DC (1994a) Attenuation of antipredator defensive behavior in Swiss-Webster mice following acute and chronic treatment with chlordiazepoxide and alprazolam. Soc Neurosci Abstr 20:811
Griebel G, Moreau J-L, Jenck F, Misslin R, Martin JR (1994b) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113:463–470
Griebel G, Blanchard DC, Jung A, Masuda CK, Blanchard RJ (1995a) 5-HT1A agonists modulate mouse antipredator defensive behavior differently than the preferential 5-HT2A antagonist pirenperone. Pharmacol Biochem Behav (in press)
Griebel G, Blanchard DC, Blanchard RJ (1995b) A model of “antipredator” defense in Swiss-Webster mice. Effects of benzodiazepine receptor ligands with different intrinsic activities. Behav Pharmacol (in press)
Hendrie CA, Neill JC (1991) An animal model of panic disorder. J Psychopharmacol 6:125 (abstract)
Horn AS (1980) The mode of action of tricyclic antidepressants: a brief review of recent progress. Postgrad Med J 56 [Suppl 1]:9–12
Humble M, Koczkas C, Wistedt B (1989) Serotonin and anxiety: an open study of citalopram in panic disorder. In: Stefanis CN, Soldatos CR, Rabavilas AD (eds) Psychiatry/Today: VIII World Congress of Psychiatry Abstracts. Elsevier, New York, p 151
Jenck F, Broekkamp CLE, Van Delft AML (1989) Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periqueductal gray aversion. Eur J Pharmacol 161:219–221
Kahn RS, Moore C (1993) Serotonin in the pathogenesis of anxiety. In: Hoehn-Saric R, McLeod DR (eds) Biology of anxiety disorders. American Psychiatric Press, Washington, pp 61–102
Kahn RS, Westenberg HGM, Verhoeven WMA, Gispen de Wied CC, Mamerbeek WDJ (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders, a double blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 2:33–45
Kahn RS, Van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208
Kilts CD, Commissaris RL, Rech RH (1981) Comparison of anticonflict drug effects in three experimental animal models of anxiety. Psychopharmacology 74:290–296
Kiser RS, German DC, Lebowitz RM (1978) Serotonergic reduction of dorsal central gray area stimulation-produced aversion. Pharmacol Biochem Behav 9:27–31
Klimek V, Zak Knapik J, Mackowiak M (1994) Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci 19:63–67
Lister RG (1990) Ethologically-based animal models of anxiety disorders. Pharmacol Ther 46:321–340
Mai J, Moryl E (1992) Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J Neural Transm [GenSect] 88:143–156
Martin P (1993) Effects of anxiolytic and antidepressant drugs in an animal model of panic. In: Hamon M, Ollat H, Thiébo MH (eds) Anxiety: neurobiology, clinical and therapeutic perspectives. John Libbey Eurotext Ltd, Paris pp 203–204
Meert TF, Colpaert FC (1986) The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds. Psychopharmacology 88:445–450
Molewijk HE, Van der Poel, AM, Vedder AW, Olivier B (1993) Ultrasonic distress vocalisations in adult rats as a model for panic disorder. British Association for Psychopharmacology, 25–28 July, Cambridge, A12 (abstract)
Mueller EA, Murphy EA, Sunderland T (1985) Neuroendocrine effects ofm-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1–6
Murphy DL, Brooks A, Aulakh C, Pigott TA (1993) Anxiolytic effects of drugs acting on 5-HT receptor subtypes. In: Vanhoutte PM, Saxena PR, Paoletti R, Brunello N, Jackson AS (eds) Serotonin — from cell biology to pharmacology and therapeutics. Kluwer Academic Publishers, Boston, pp 223–230
Nutt DJ, Glue P (1991) Imipramine in panic disorder: I. Clinical response and pharmacological changes. J Psychopharmacol 5:56–64
Onaivi ES, Martin BR (1989) Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 13:963–976
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Rutter JJ, Auerbach SB (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 265:1319–1324
Saletu B, Grünberger J (1985) Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG and psychometric analyses. Clin Psychiatry 46:45–52
Sanger DJ (1990) Effects of buspirone and related compounds on suppressed operant responding in rats. J Pharmacol Exp Ther 254:420–426
Sanger DJ (1992) Increased rates of punished responding produced by buspirone-like compounds in rats. J Pharmacol Exp Ther 261:513–517
Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10:119–121
Schütz MTB, de Aguiar JC, Graeff FG (1985) Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology 85:340–345
Treit D (1991) Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 107–131
Van Praag HM (1988) Serotonin disturbances in psychiatric disorders: functional versus nosological interpretation. Adv Biol Psychiatry 17:52–57
Westenberg HGM, Den Boer JA (1988) Clinical and biochemical effects of selective serotonin-uptake inhibitors in anxiety disorders. Adv Biol Psychiatry 17:84–99
Westenberg HGM, Den Boer JA (1993) Serotonin and related disorders. In: Vanhoutte PM, Saxena PR, Paoletti R, Brunello N, Jackson AS (eds) Serotonin — from cell biology to pharmacology and therapeutics. Kluwer Academic Publishers, Boston, pp 249–254
Young R, Johnson DN (1991) A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40:739–743
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Griebel, G., Blanchard, D.C., Agnes, R.S. et al. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 120, 57–66 (1995). https://doi.org/10.1007/BF02246145
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246145